Tevogen Inc. — Form SCHEDULE 13D/A
Filed September 16, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 15/100
What the filing says
An amended Schedule 13D/A was filed on 2026-09-16 by filer Desai Kirti (CIK 0002011765) regarding Tevogen Inc. (market cap ~$63.7M). The filing document itself contains only header/metadata information and no substantive disclosure of beneficial ownership changes, share count, percentage holdings, or transaction details. The actual amendment content is not readable in the provided text.
Why this rating
Cannot assess significance without actual amendment disclosure. Stub filing contains only administrative metadata; no material facts about ownership, transactions, or holdings are visible.
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.